Vimarsana
Biggest News Aggregation in the World

Page 3 - Germ Quest News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Germ Quest. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Germ Quest Today - Breaking & Trending Today

Nobody finds the Alzheimer's Germ in $1 Million Challenge, but eight researchers split $200K, says Dr. Leslie Norins of Alzheimer's Germ Quest - Vimarsana News

Nobody finds the Alzheimer's Germ in $1 Million Challenge, but eight researchers split $200K, says Dr. Leslie Norins of Alzheimer's Germ Quest

Share this article Share this article NAPLES, Fla., Feb. 23, 2021 /PRNewswire/ -- Eight final honorees will divide $200,000 for meritorious entries in Alzheimer's Germ Quest's "$1 Million Challenge", which lasted three years, ending December 31, 2020, says Leslie Norins, MD, PhD, FIDSA (Emeritus), CEO. However, nobody provided persuasive-enough evidence that a particular infectious agent was the sole cause of Alzheimer's disease, so the grand prize of $1 million will not be awarded. Summary results are posted online. The challenge initially attracted 81 would-be entrants, of whom 40 were aut...

Us Against Alzheimer's advocacy group must reveal financial conflict of interest to FDA, says Dr. Leslie Norins of Alzheimer's Germ Quest - Vimarsana News

Us Against Alzheimer's advocacy group must reveal financial conflict of interest to FDA, says Dr. Leslie Norins of Alzheimer's Germ Quest

Share this article Share this article NAPLES, Fla., Feb. 16, 2021 /PRNewswire/ -- The advocacy group Us Against Alzheimer's (UsA2) did not reveal in its January 19 letter to the FDA urging approval of aducanumab for Alzheimer's disease it had received monies from the drug's maker, Biogen, says Leslie Norins, MD, PhD, CEO of Alzheimer's Germ Quest.    For example, Biogen and its co-venturer, Esai, were both listed as "Premier" sponsors of the virtual Alzheimer's symposium presented by UsA2 in November 2020.  The "premier" designation was ranked even higher than "platinum," but it...

Daniel Czyz gets $100K for Alzheimer's disease research - Vimarsana News

Daniel Czyz gets $100K for Alzheimer's disease research

Daniel Czyz, Ph.D., assistant professor at the University of Florida, is one of 10  researchers exploring the link between an infectious agent and Alzheimer’s disease who have each been awarded $100,000 research grants through the Infectious  Diseases Society of America (IDSA) Foundation’s Microbial Pathogenesis in Alzheimer’s Disease Grant program. Since the program was established in 2018, the IDSA Foundation has provided more than $600,000 to seven researchers, making the 2020 awardees the largest recipient pool to date. The program will provide an additional pilot grant of $8,000...

Alzheimer's microbe hypothesis gets major NIH funding - Vimarsana News

Alzheimer's microbe hypothesis gets major NIH funding

/PRNewswire/ -- The NIH's National Institute on Aging announced on January 15 that a cornucopia of research grants is now offered to probe infectious...

IDSA Foundation Announces More Than $1 Million in Grant Funds for Researchers Linking Infectious Agents in Alzheimer's Disease - Vimarsana News

IDSA Foundation Announces More Than $1 Million in Grant Funds for Researchers Linking Infectious Agents in Alzheimer's Disease

IDSA Foundation Announces More Than $1 Million in Grant Funds for Researchers Linking Infectious Agents in Alzheimer’s Disease Newswise — ARLINGTON, Va. (January 12, 2021) – Ten researchers who are exploring the link between an infectious agent and Alzheimer’s disease have each been awarded $100,000 research grants through the IDSA Foundation’s Microbial Pathogenesis in Alzheimer’s Disease Grant program. Since the program was established in 2018, the IDSA Foundation has provided more than $600,000 to seven researchers, making the 2020 awardees the largest recipient pool to date...